Source comparison
BPC-157 Diabetic Neuropathy Research Mechanism: Comparison
Streptozotocin diabetic rats (nerve crush) VEGF upregulation + angiogenesis 47% faster motor recovery vs control Moderate. Replicable in multiple labs Does not model chronic progressive neuropathy. Uses acute injury Diabetic rat SNCV study Axonal regeneration
This comparison does not assign a generated winner or score.
- Streptozotocin diabetic rats (nerve crush)
- VEGF upregulation + angiogenesis
- 47% faster motor recovery vs control
- Moderate. Replicable in multiple labs
- Does not model chronic progressive neuropathy. Uses acute injury
- Diabetic rat SNCV study
- Axonal regeneration + remyelination
- SNCV improved 28 m/s → 39 m/s over 8 weeks
- Moderate. Objective functional measure
- Hyperglycemia not corrected. Mechanism independent of glucose
- In vitro endothelial cell culture
- VEGFR2 binding + PI3K/Akt activation
- 3.2× increase in capillary-like tube formation
- High for mechanism clarity
- No systemic metabolism or nerve tissue context
- Human clinical trial (any neuropathy indication)
- Not yet studied
- No data
- None
- Lack of translational research is the critical gap